TCL Archive Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner. July 4, 2003
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004